Cv personal information
Download 19.42 Kb.
|
- Navigate this page:
- Education and professional position ：
- Grant support: 1.
- Teaching Responsibility: Genomics and Post-genomics (Lecture) Major Publications
- Hum Genet (IF=5.05).
- Corresponding author ) 3. Lei Wang
- IF=14.2 ) 4. Jie Ma, Dongming Li, Rui Zhang, Xudong Yang, Shemin Lu, Chengge Gao, Shengnan Wu and Lei Wang*
- IF=3.15 , Corresponding author ） 6. Lei Wang
- Journal of psychopharmacology
- IF=2.1 ) 9. Shih PA, Wang L
- Pharmacogenet Genomics
- . Progress in Neuropsychopharmacology Biological Psychiatry
| CV
Personal information: Name: Lei Wang Date of birth：09/21/1982 Address: Institutes of Biomedical Sciences, Fudan University Room 307, Mingdao Building, No131 Dong An Road，200032 TEL: 021-54237860；13918012683 Email: wangleiwanglei@fudan.edu.cn
2011.9-present Associate Professor, Institutes of Biomedical Sciences, Fudan University 2009.4-2011.8 Assistant Professor, Institutes of Biomedical Sciences, Fudan University 2007-2008 Visiting Scholar, Department of Medicine and Molecular biology, University of California, San Diego 2004-2009 Ph.D in Biochemistry and Molecular biology, Shanghai Jiao Tong University
2007 National Excellent Ph.D. candidate scholarship (Shanghai Jiao Tong University) Grant support: 1. Major State Basic Research Development Program of China (973 Program): The functional and molecular mechanism study of deafness genes. (NO 2011CB504502, 2011-2014) 2. Major State High-tech development program of China (863 Program): The development of reagent for major genetics diseases (No 2011AA02112，2011-2015) 3. The National Natural Science Foundation of China: The study of microRNA differentiated profiling in follicular fluids in PCOS (No 81100467, 2012-2014)
Major Publications: 1. Li Q, Yang G, Wang Y, Zhang X, Sang Q, Wang H, Zhao X, Xing Q, He L, Wang L*. Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients. Hum Genet (IF=5.05). 2011 May;129(5):553-61 (Corresponding author) 2. Wang H, Li Q, Wang T, Yang G, Wang Y, Zhang X, Sang Q, Wang H, Zhao X, Xing Q, Shi J, He L, Wang L*. A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro. Mol Hum Reprod (IF=3.5). 2011 Jun;17(6):386-91 (Corresponding author) 3. Lei Wang, Fangwen Rao, Kuixing Zhang, etc. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. Journal of the American College Cardiology. 2009 Sep 1;54 (10):944-54. (IF=14.2) 4. Jie Ma, Dongming Li, Rui Zhang, Xudong Yang, Shemin Lu, Chengge Gao, Shengnan Wu and Lei Wang*. Genetic analysis of glutamate cysteine ligasemodifier (GCLM) gene and schizophrenia in Han Chinese. Schizophrenia research 2010 119(273-274) (IF=4.45, Corresponding author) 5. Lei Wang*, Ying Wang, Yaping Zhang, etc. Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance and insulin secretion in Polycystic Ovary Syndrome patients. Fertility and Sterility 2010 Nov;94(6):2486-9, 2489.e1-2 (IF=3.15, Corresponding author） 6. Lei Wang, Lan Yu, Ai-Ping Zhang, Jing Dua,Niu-Fan Guc,Sheng-Ying Qin,Guo-Yin Feng,Xing-Wang Li,Qing-He Xing, Lin He. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia. Journal of psychopharmacology 2007 Nov; 21(8):837-42 (IF=4.06) 7. Lei Wang, Chao Fang, Aiping Zhang, Jing Du, Lan Yu, Guoyin Feng, Qinghe Xing,Lin He. The -1019 C/G polymorphism of 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients. Journal of psychopharmacology 2008 Nov;22(8):904-9 (IF=4.06) 8. Lei Wang, Lan Yu, Guang He, Jing Zhang, Ai-Ping Zhang, Jing Du, Rui-Qi Tang, Xin-Zhi Zhao. Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neuroscience Letter, 414 (2007) 1-4. (IF=2.1) 9. Shih PA, Wang L, Chiron S, Wen G, Nievergelt C, etc. Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo. J Clin Endocrinol Metab. 2009 Nov;94(11):4557-66 (IF=6.3) 10. Gu B, Wang L, Zhang AP, Ma G, Zhao XZ, Li HF, Feng GY, He L, Xing QH.Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients. Pharmacogenet Genomics. 2008 Aug; 18(8):721-7 (IF=4.4) 11. Zhiyun Wei, Lei Wang, Jiekun Xuan, Ronglin Che, Jing Du, Shengying Qin, Yi Xing, Bo Gu, Lun Yang,et al. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients. Progress in Neuropsychopharmacology & Biological Psychiatry. 2009 Apr 30;33(3):547-51 (IF=2.6) 12. Zhang A, Xing Q, Wang L, Du J, He L. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics. 2007 Oct; 8(10):1337-1345 （IF=3.5）10):1337-1345 （IF=3.5） Download 19.42 Kb. Share with your friends:
|